Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial
Authors:
- F.M. RussellFRF.M. Russell
- J.R. CarapetisJCJ.R. Carapetis
- G.B. ByrnesGBG.B. Byrnes
- M.L.K. TangMTM.L.K. Tang
- 1 April 2010
- Vol. 28 (19) , 3341-3349
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccineVaccine, 2009
- Reconsideration of the Use of Meningococcal Polysaccharide VaccineThe Pediatric Infectious Disease Journal, 2007
- Discovery of a New Capsular Serotype (6C) within Serogroup 6 ofStreptococcus pneumoniaeJournal of Clinical Microbiology, 2007
- Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccineVaccine, 2004
- Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infantsVaccine, 2003
- Blood Dendritic Cells Interact with Splenic Marginal Zone B Cells to Initiate T-Independent Immune ResponsesImmunity, 2002
- Immunologic Memory 5 Years after Meningococcal A/C Conjugate Vaccination in InfancyThe Journal of Infectious Diseases, 2001
- Lipopolysaccharide induces apoptotic cell death of B memory cells and regulates B cell memory in antigen-nonspecific mannerFEMS Immunology & Medical Microbiology, 1996
- IMMUNOLOGICAL PARALYSIS TO PNEUMOCOCCAL POLYSACCHARIDE IN MANThe Lancet, 1985
- Efficacy of Pneumococcal Polysaccharide Vaccine in Preventing Acute Otitis Media in Infants in Huntsville, AlabamaClinical Infectious Diseases, 1981